OMB is
withholding approval at this time. Prior to publication of the
final rule, the agency should provide a summary of any comments
related to the information collection and their response, including
any changes made to the ICR as a result of comments. In addition,
the agency must enter the correct burden estimates.
Inventory as of this Action
Requested
Previously Approved
36 Months From Approved
0
0
0
0
0
0
0
0
0
This ICR collects information from
manufacturers, distributors, and certain retailers of cigarettes
who will be required to submit plans to FDA relating to the random
and equal display and distribution of required warning statements
on cigarette packaging and quarterly rotation of required warning
statements in alternating sequence in cigarette product advertising
("plan" or "plans"). A record of the FDA-approved plan must also be
established and maintained.
US Code:
21
USC 387c Name of Law: Federal Food, Drug, and Cosmetic Act
US Code: 21
USC 387i Name of Law: Federal Food, Drug, and Cosmetic Act
PL:
Pub.L. 111 - 31 123 Name of Law: Tobacco Control Act
US Code: 21
USC 371 Name of Law: Federal Food, Drug, and Cosmetic Act
US Code: 21
USC 374 Name of Law: Federal Food, Drug, and Cosmetic Act
US Code: 21
USC 387e(g) Name of Law: Federal Food, Drug, and Cosmetic
Act
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.